A single‐ and multiple‐ascending dose study to evaluate the safety and pharmacokinetics of oral PU‐AD, an epichaperome inhibitor to treat Alzheimer’s diseaseMichael Silverman,Barbara Wallner,Cassandra Key, Susan M. Duggan, Laurie ReynoldsAlzheimers & Dementia（2020）引用 2|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
